For individuals who've plateaued on tirzepatide or semaglutide, by far the most proof-based subsequent stage in 2026 is optimizing the current protocol. Adjusting dose timing, revisiting macronutrient distribution, or incorporating resistance coaching to preserve lean mass in the course of continued weight loss. Moreover, ongoing research is inv